Kita-kyushu Lung Cancer Antigen 1, Human
1 clinical trials · Condition
◉ Watch Kita-kyushu Lung Cancer Antigen 1, Human
| Record | Firm | Date |
|---|---|---|
| T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers (NCT05035407) | National Cancer Institute (NCI) | 2022-03-08 |
Track Kita-kyushu Lung Cancer Antigen 1, Human automatically
Every clearance here is in the API, with alerts when new ones post.